Injectable asthma drug resolves dangerous food allergies in one-third of children
More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an ...
Hosted on MSN2d
Rare Food Allergy Syndrome Increasingly Due to Early Egg, Peanut Introduction?
Common triggers for food protein-induced enterocolitis syndrome (FPIES) have shifted, and more cases than expected have ...
KalVista Pharmaceuticals Shares Latest Sebetralstat Findings at the American Academy of Allergy, Asthma & Immunology 2025 Annual Meeting
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the presentation of novel sebetralstat data related to ...
HealthDay on MSN2d
AAAAI: Omalizumab Superior to Oral Immunotherapy in Multifood Allergy
Omalizumab is superior to oral immunotherapy (OIT) for multifood allergy, and most patients include dietary consumptio ...
Some kids may successfully eat trigger foods after stopping anti-allergy med, early study suggests
The study of success eating food triggers after stopping Xolair is ongoing, so researchers are still collecting data for doctors to use making treatment plans with their patients. Parents interested ...
Monthly Prescribing Reference2d
Omalizumab vs OIT: Head-to-Head Study Compares Food Allergy Treatments
Omalizumab was found to be more effective than multi-allergen oral immunotherapy (OIT) in reducing allergic reactions in patients with 1 or more food allergies, according to results from Stage 2 of ...
BioSpace2d
First Head-to-Head Study Cements Roche’s Xolair as Food Allergy Leader
Roche’s asthma drug Xolair appears to be safer and more effective than oral immunotherapy at treating adults and children ...
Hosted on MSN1d
Formula Soon After Birth Linked to Food Allergy Risk
Infants exclusively breastfed in the first 3 days of life had fewer food allergies at 1 year of age than those who also got ...
News Medical on MSN1d
Omalizumab treats multi-food allergy better than oral immunotherapy: Study
Omalizumab treats multi-food allergy better than oral immunotherapy: Study: Bethesda, Maryland Wednesday, March 5, 2025, 11:00 Hrs [IST] A clinical trial has found that the medica ...
Healio3d
44% of patients with acute exacerbations of COPD have hypogammaglobulinemia
Immunoglobulin G hypogammaglobulinemia was found in 44.7% of patients with acute exacerbations of COPD receiving triple ...
Pharvaris reports safety and efficacy data of deucrictibant
Pharvaris (PHVS) highlighted safety and efficacy data of deucrictibant, which is currently being evaluated in two pivotal Phase 3 studies, ...
Morningstar2d
KalVista Pharmaceuticals Shares Latest Sebetralstat Findings at the American Academy of Allergy, Asthma & Immunology 2025 Annual Meeting
attacks and adolescents with HAE at the American Academy of Allergy, Asthma & Immunology (AAAAI) / World Allergy Organization (WAO) 2025 Joint Congress taking place in San Diego, CA from February ...